According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to it each year. To better understand the nuances and factors contributing to the disease and its complications, IHH Malaysia became the first Platinum Sponsor of the Seremban Diabetes (SeDia) Cohort Study in Malaysia, with a contribution of RM 2 million.
Jean-François Naa, CEO of IHH Malaysia, presented a mock cheque at the launch of the longitudinal study by the Ministry of Health and International Medical University on 08 July 2023.
The SeDia Cohort Study will encompass a comprehensive examination of various factors, from genetics and family history of diabetes to lifestyle and environmental factors, dietary regimes, physical activity, socio-economic levels and healthcare delivery. By understanding the complex connections between these factors, the aim is to uncover optimal strategies for diabetes prevention and treatment.
Subsequently, this knowledge can be translated into evidence-based public healthcare policies and programmes that are relevant to the local community. This ensures the efficacy of developed treatment and prevention initiatives in addressing the escalating burden of diabetes in Malaysia.
This 12-year study marks the first important step towards obtaining data that is socio-culturally relevant to the local community. It involves over 5,000 patients registered as part of the Klinik Kesihatan Seremban’s Diabetes Registry and over 7,000 of their family members, to investigate the complex web of interactions that contribute to the development of diabetes and its complications.
Related Stories
Parkway Radiology Reopens Upgraded Nuclear Medicine and PET Centre at Mount Elizabeth Hospital
Parkway Radiology’s Nuclear Medicine and PET Centre at Mount Elizabeth Hospital has officially reopened following a comprehensive renovation, offering an enhanced patient experience within a modern and welcoming environment.
IHH Healthcare Sponsors Health and Wellness Journalism Award at Singapore Press Club Awards 2026
IHH Healthcare is proud to sponsor the Health and Wellness Journalism Award at the Singapore Press Club Awards 2026.
Fortis Achieves Stronger ESG Rating and Rises to #2 Among Healthcare Peers
Fortis Healthcare has received its latest ESG rating from the National Stock Exchange, and we are pleased to share significant progress in both our score and sector ranking.
Gleneagles Hospital Hong Kong Advances Regional Collaboration in Venous Disease Care
Gleneagles Hospital Hong Kong, part of the IHH Healthcare network, has entered into a strategic partnership with the Asian Venous Academy and Dr Smile Medical Group to advance collaboration in venous disease related services, research and education.
IHH Singapore and Medistra Hospital Sign MoU to Strengthen Liver Disease Care in the Region
IHH Healthcare Singapore and Medistra Hospital signed a Memorandum of Understanding (MoU) on 22 January 2026, marking a significant step forward in advancing liver disease services and strengthening healthcare quality across the region.
Pantai Hospital Kuala Lumpur Performs Combined Airway and Heart Surgery on One-Year-Old
A multidisciplinary team at Pantai Hospital Kuala Lumpur has successfully performed a combined surgery to repair both the airway and heart of a one-year-old child, addressing two life-threatening conditions in a single operation.
